David Miklos, MD, PhD of Stanford University Medical Center discusses the big news surrounding ibrutinib for Graft-versus-Host Disease at the 58th ASH Annual Meeting in San Diego, CA.
Big News at ASH 2016 is Ibrutinib in Treatment of GVHD
David Miklos, MD, PhD of Stanford University Medical Center discusses the big news surrounding ibrutinib for Graft-versus-Host Disease at the 58th ASH Annual Meeting in San Diego, CA.